Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer.

This work describes a list of potential ADC targets in TNBC and validates one of them, the transmembrane protein CD98hc. The studies presented here also demonstrate the robustness of the multiomic approach herewith described to identify novel potential ADC targets.